Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001493152-22-019041
Filing Date
2022-07-12
Accepted
2022-07-12 06:20:32
Documents
4

Document Format Files

Seq Description Document Type Size
1 form424b5.htm 424B5 585945
2 form424b5_001.jpg GRAPHIC 10855
3 form424b5_002.jpg GRAPHIC 10855
4 form424b5_003.jpg GRAPHIC 32209
  Complete submission text file 0001493152-22-019041.txt   661550
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-263855 | Film No.: 221078174
SIC: 2834 Pharmaceutical Preparations